Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

EU Industry Welcomes New Schengen Strategy’s Green Lanes

7 April 2021

Open

New report assesses progress on biosimilar medicine policies across Europe

29 March 2021

Biosimilar medicines are increasingly relevant to public health as emphasised by the […]

Read more

A new medicines trade and health security agenda for the European Commission

19 February 2021

In response to the European Commission Trade Communication published on […]

Read more

No further excuse to delay digital regulatory infrastructure for medicines after Covid-19 pandemic

19 February 2021

Open

Smarter use of generic, biosimilar and value added medicines will ensure equitable access to cancer care

4 February 2021

Open

AESGP, EFPIA and Medicines for Europe reflections on the European Medicines Agency, the Heads of Medicines Agencies and the European Commission “Key principles for the use of electronic product information for EU medicines” press release.

3 February 2021

Open

Window of opportunity to enhance EU regulatory systems wide open as EU pharma strategy prioritises stronger EU networks

19 January 2021

Open

EU digital strategy requires investments in the digitalisation of Europe’s medicines regulatory agencies to succeed

15 January 2021

Open

All routes to healthcare efficiency include biosimilar medicines

9 December 2020

Open

EU Pharma Strategy: Success depends on access to Generic, Biosimilar and Value Added Medicines

25 November 2020

Open

Subscribe to our newsletter